Trademark: 97748253
Word
NIPPON CHEMIPHAR
Status
Pending
Status Code
686
Status Date
Tuesday, July 16, 2024
Serial Number
97748253
Mark Type
4
Filing Date
Tuesday, January 10, 2023
Published for Opposition
Tuesday, July 16, 2024

Trademark Owner History
Nippon Chemiphar Co., Ltd. - Owner At Publication

Classifications
5 Pharmaceutical preparations for Cardiovascular Disorders, Genitourinary Disorders, Gynecological diseases, Cancer and cancer supportive care, Eye Disorders, Neurologic Disorders, Psychiatric Disorders, Endocrine and Metabolic Disorders, Allergic Disorders, Gastrointestinal Disorders, Immune Diseases and Autoimmune Diseases, Respiratory Diseases, Musculoskeletal and Connective Tissue Disorders, Infectious Diseases, Dermatologic Disorders, Hematological Disorder, Inflammatory Diseases, Ear, Nose, Dental and Throat Disorders, Hepatic and Biliary Disorders, Kidney Diseases, Medicines for improving sleep, Medicines for controlling sickness from drinking, Medicines for controlling hangovers; Obstetric medicines being medical preparations for the treatment of endometriosis or adenomyosis; local, topical, general, inhalant anesthetic; Sedatives; Analgesic drugs; Alkalinizing agents being preparations for the lowering pH levels in patients; Anti-aging agents being pharmaceutical preparations for reducing the effects of aging in patients; reagent paper for medical purposes; pharmaceutical preparations for reducing pain, reducing inflammation; pharmaceutical preparations and substances with antipyretic properties anti-inflammatories and analgesic properties for the treatment of nociceptive pains, the treatment of neuropathic pains, the treatment of visceral pains, the treatment of rheumatoid arthritis, the treatment of low back pain, and the treatment of after surgery, trauma, and tooth extraction; pharmaceutical preparations for the treatment of gout and hyperuricemia; Pharmaceutical preparations for treating hypertension; pharmaceutical preparations and substances for the treatment of cancer; Hygiene agent, namely, medical cleanser for skin and wounds; Eye patches and skin patches for medical purposes, namely, pharmaceutical preparations for reducing pain, reducing inflammation; medicated ointments for treating dermatological conditions; Infusion drug for medical purposes, namely, pharmaceutical preparations for reducing pain, reducing inflammation that need to be administered gradually intravenously; Diagnostic agents and reagents for medical use; diagnostic reagents for medical purposes; Medical diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; In vitro diagnostic reagent for medical use; In vitro diagnostic reagents kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in determining allergies; medical oiled paper; Drug delivery agents in the form of wafers for wrapping powdered pharmaceuticals for medicine doses; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages spray; Breast-nursing pads; cotton swabs for medical use; lacteal flour for babies; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; Vitamin fortified beverages for babies for medical purposes; food for babies; dietary-supplements-for-animals other than drugs; Semen for artificial insemination; ferments for pharmaceutical purposes; Food supplements, namely, antioxidant pills; dietary supplements for anti-aging immune system for humans; appetite suppressant pills; dietary fiber to aid digestion; pharmaceutical preparations for treating dry skin; Pharmaceutical preparations being medical application cream pharmaceuticals for treating skin conditions; pharmaceutical preparations for skin care; Nasal sprays for medical purposes
1 Diagnostic reagents for medical research; Diagnostic reagent kits consisting of chemical reagents, cell culture reagents, biochemical reagents for medical research
10 Medical apparatus and instruments, namely, medical devices for use in diagnosing allergies; Medical diagnostic apparatus and instruments for diagnostic for immunotherapy medical purposes; Medical diagnostic apparatus and instruments, namely, medical devices for use in diagnosing allergies; apparatus for use in medical purpose for identifying allergens causing allergy, namely, medical devices for use in diagnosing allergies; medical diagnostic apparatus for testing and quantifying the amount of allergen-specific antibody; Genetic testing apparatus for medical purposes; medical measuring apparatus, namely, medical apparatus for measuring skin hydration; Medical diagnostic apparatus for measuring, testing and analyzing specimens reacted with diagnostic reagents; medical diagnostic apparatus, namely, immunoassay analyzer being medical diagnostic apparatus for testing for viruses; mobile medical apparatus for enzyme-linked immunosorbent assay, namely, medical diagnostic apparatus for testing for blood protein, DNA for allergy screening; medical diagnostic apparatus for testing and measuring specific immunoglobulin E (IgE) antibodies; Sanitary masks for personal use; dental materials being dental implants
The English translation of NIPPON in the mark is Japan.
"NIPPON"

Trademark Events
Jan 13, 2023
New Application Entered
Jan 31, 2023
New Application Office Supplied Data Entered
Oct 3, 2023
Assigned To Examiner
Oct 5, 2023
Non-Final Action Written
Oct 5, 2023
Non-Final Action E-Mailed
Oct 5, 2023
Notification Of Non-Final Action E-Mailed
Jan 4, 2024
Teas Response To Office Action Received
Jan 4, 2024
Correspondence Received In Law Office
Jan 5, 2024
Teas/Email Correspondence Entered
May 22, 2024
Examiners Amendment E-Mailed
May 22, 2024
Notification Of Examiners Amendment E-Mailed
May 23, 2024
Examiners Amendment E-Mailed
May 23, 2024
Examiners Amendment -Written
Feb 23, 2024
Final Refusal Written
Feb 23, 2024
Final Refusal E-Mailed
Feb 23, 2024
Notification Of Final Refusal Emailed
May 22, 2024
Examiners Amendment -Written
May 22, 2024
Examiner's Amendment Entered
May 23, 2024
Notification Of Examiners Amendment E-Mailed
May 23, 2024
Examiner's Amendment Entered
May 28, 2024
Approved For Pub - Principal Register
May 30, 2024
On Hold - Electronic Record Review Required
Jun 26, 2024
Notification Of Notice Of Publication E-Mailed
Jul 16, 2024
Published For Opposition
Jul 16, 2024
Official Gazette Publication Confirmation E-Mailed
Jul 16, 2024
Published For Opposition
Jul 16, 2024
Official Gazette Publication Confirmation E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24